Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Werewolf Therapeutics Inc

HOWL
1,32
-0,03 (-2,22%)
01 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202514:00GLOBEWerewolf Therapeutics Provides Business Update and..
06/1/202523:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202523:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202523:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202414:00GLOBEWerewolf Therapeutics to Participate in the 7th Annual..
07/11/202415:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202415:06EDGAR2Form 8-K - Current report
07/11/202415:02GLOBEWerewolf Therapeutics Presents Preclinical and Clinical Data..
07/11/202415:00GLOBEWerewolf Therapeutics Reports Third Quarter 2024 Financial..
31/10/202413:00GLOBEWerewolf Therapeutics Announces Promising New Development..
04/10/202415:00GLOBEWerewolf Therapeutics to Present Posters at the Society for..
03/9/202414:00GLOBEWerewolf Therapeutics to Participate in the H.C. Wainwright..
08/8/202413:21EDGAR2Form S-8 POS - Securities to be offered to employees in..
08/8/202413:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:07EDGAR2Form 8-K - Current report
08/8/202413:05GLOBEWerewolf Therapeutics Reports Second Quarter 2024 Financial..
25/6/202413:00GLOBEWerewolf Therapeutics Highlights Initial Safety and Efficacy..
03/6/202413:56EDGAR2Form 8-K - Current report
01/6/202415:00GLOBEWerewolf Therapeutics to Present Data from Ongoing Phase..
30/5/202414:00GLOBEWerewolf Therapeutics to Participate at the Jefferies Global..
28/5/202422:27EDGAR2Form 8-K - Current report
25/5/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202401:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:00GLOBEWerewolf Therapeutics to Present Updated Data from Phase..
03/5/202413:00GLOBEWerewolf Therapeutics Reports First Quarter 2024 Financial..
24/4/202416:05GLOBEWerewolf Therapeutics Announces WTX-124 Clinical Abstract..
23/4/202414:00GLOBEWerewolf Therapeutics Presents First Preclinical Data..
05/4/202422:30GLOBEWerewolf Therapeutics Presents Preclinical Results..
04/4/202422:30GLOBEWerewolf Therapeutics to Present First-of-Its-Kind Data..
07/3/202413:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202413:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202413:11EDGAR2Form 8-K - Current report
07/3/202413:00GLOBEWerewolf Therapeutics Reports Fourth Quarter and Full Year..
06/3/202414:00GLOBEWerewolf Therapeutics to Present at the 2024 Leerink..
05/3/202422:30GLOBEWerewolf Therapeutics Announces Upcoming Presentations at..
09/2/202422:39EDGAR2Form 8-K - Current report
09/2/202422:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
Apertura: 1,35 Min: 1,315 Max: 1,40
Chiusura: 1,35

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network